Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 21.79 · gapped above the open, then crossed back over prior close. High/low 22.39 at 8:15 am ET, 21.44 at 10:45 am ET.
Viridian Therapeutics, Inc.\DE
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
VRDN (Viridian Therapeutics, Inc.\DE) has 6 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ZLAB +0.13%, in industrials & materials.
217 institutional managers report a position in Viridian Therapeutics, Inc.\DE worth $2.5B between them, filed on form 13F for the quarter ending 2026-06-30. 30 of them hold 80% of it, the largest being FMR LLC at 12.15%.
192 more managers in the register
30 managers hold 80% of the $2.5B institutional base. The other 187 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Kynam Capital Management, LP, Deep Track Capital, LP, Wellington Management Group LLP +10 more · 4.72% of VRDN, 6.21% of CLDX
via Bellevue Group AG, Paradigm Biocapital Advisors LP, Fairmount Funds Management LLC +4 more · 4.93% of VRDN, 4.19% of JBIO
via Bellevue Group AG, Kynam Capital Management, LP, Wellington Management Group LLP +8 more · 4.93% of VRDN, 5.28% of IMCR
via Kynam Capital Management, LP, VR Adviser, LLC, Wellington Management Group LLP +6 more · 4.72% of VRDN, 10.26% of CTMX
via Fairmount Funds Management LLC, Paradigm Biocapital Advisors LP, Deep Track Capital, LP +5 more · 3.73% of VRDN, 4.98% of ORKA
via Paradigm Biocapital Advisors LP, Deep Track Capital, LP, Wellington Management Group LLP +6 more · 4.92% of VRDN, 4.47% of MBX
Managers holding a meaningful stake in VRDN also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.